<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31330533</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>572</Volume><Issue>7770</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Potential roles of gut microbiome and metabolites in modulating ALS in mice.</ArticleTitle><Pagination><StartPage>474</StartPage><EndPage>480</EndPage><MedlinePgn>474-480</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-019-1443-5</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disorder, in which the clinical manifestations may be influenced by genetic and unknown environmental factors. Here we show that ALS-prone Sod1 transgenic (Sod1-Tg) mice have a pre-symptomatic, vivarium-dependent dysbiosis and altered metabolite configuration, coupled with an exacerbated disease under germ-free conditions or after treatment with broad-spectrum antibiotics. We correlate eleven distinct commensal bacteria at our vivarium with the severity of ALS in mice, and by their individual supplementation into antibiotic-treated Sod1-Tg mice we demonstrate that Akkermansia muciniphila (AM) ameliorates whereas Ruminococcus torques and Parabacteroides distasonis exacerbate the symptoms of ALS. Furthermore, Sod1-Tg mice that are administered AM are found to accumulate AM-associated nicotinamide in the central nervous system, and systemic supplementation of nicotinamide improves motor symptoms and gene expression patterns in the spinal cord of Sod1-Tg mice. In humans, we identify distinct microbiome and metabolite configurations-including reduced levels of nicotinamide systemically and in the cerebrospinal fluid-in a small preliminary study that compares patients with ALS with household controls. We suggest that environmentally driven microbiome-brain interactions may modulate ALS in mice, and we call for similar investigations in the human form of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Blacher</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bashiardes</LastName><ForeName>Stavros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shapiro</LastName><ForeName>Hagit</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rothschild</LastName><ForeName>Daphna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor</LastName><ForeName>Uria</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dori-Bachash</LastName><ForeName>Mally</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleimeyer</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moresi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harnik</LastName><ForeName>Yotam</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zur</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabari</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular/EMG service and ALS/Motor Neuron Disease Clinic, Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brik</LastName><ForeName>Rotem Ben-Zeev</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kviatcovsky</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zmora</LastName><ForeName>Niv</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Yotam</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar</LastName><ForeName>Noam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Izhak</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amar</LastName><ForeName>Nira</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehlman</LastName><ForeName>Tevie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandis</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Services, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biton</LastName><ForeName>Inbal</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuperman</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoory</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfahel</LastName><ForeName>Leenor</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmelin</LastName><ForeName>Alon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israelson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Ben-Gurion University of the Negev, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arike</LastName><ForeName>Liisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Malin E V</ForeName><Initials>MEV</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansson</LastName><ForeName>Gunnar C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotkine</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular/EMG service and ALS/Motor Neuron Disease Clinic, Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. marc@gotkine.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. eran.segal@weizmann.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel. eran.segal@weizmann.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elinav</LastName><ForeName>Eran</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunology Department, Weizmann Institute of Science, Rehovot, Israel. eran.elinav@weizmann.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer-Microbiome Research, DKFZ, Heidelberg, Germany. eran.elinav@weizmann.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>25X51I8RD4</RegistryNumber><NameOfSubstance UI="D009536">Niacinamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000647304">Akkermansia muciniphila</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086102" MajorTopicYN="N">Akkermansia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005856" MajorTopicYN="N">Germ-Free Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009536" MajorTopicYN="N">Niacinamide</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013559" MajorTopicYN="N">Symbiosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061327" MajorTopicYN="N">Verrucomicrobia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31330533</ArticleId><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pii">10.1038/s41586-019-1443-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Turner, M. R. et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12, 310&#x2013;322 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon, G., Lacomblez, L. &amp; Meininger, V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N. Engl. J. Med. 330, 585&#x2013;591 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Group, Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16, 505&#x2013;512 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, F. C. et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 73, 803&#x2013;811 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu, P., Blacher, E., Elinav, E. &amp; Pettersson, S. Our gut microbiome: the evolving inner self. Cell 171, 1481&#x2013;1493 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi, A. &amp; Hardiman, O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617&#x2013;628 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease. Cell 167, 1469&#x2013;1480.e12 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon, G. et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell 177, 1600&#x2013;1618.e17 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher, E., Levy, M., Tatirovsky, E. &amp; Elinav, E. Microbiome-modulated metabolites at the interface of host immunity. J. Immunol. 198, 572&#x2013;580 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601247</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga-Fernandes, H. &amp; Mucida, D. Neuro&#x2013;immune interactions at barrier surfaces. Cell 165, 801&#x2013;811 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon, G., Sampson, T. R., Geschwind, D. H. &amp; Mazmanian, S. K. The central nervous system and the gut microbiome. Cell 167, 915&#x2013;932 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, S., Yi, J., Zhang, Y. G., Zhou, J. &amp; Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3, e12356 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. G. et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 39, 322&#x2013;336 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, X. et al. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front. Microbiol. 7, 1479 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27703453</ArticleId><ArticleId IdType="pmc">5028383</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner, D. et al. The fecal microbiome of ALS patients. Neurobiol. Aging 61, 132&#x2013;137 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralph, G. S. et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11, 429&#x2013;433 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1205</ArticleId></ArticleIdList></Reference><Reference><Citation>Aartsma-Rus, A. &amp; van Putten, M. Assessing functional performance in the mdx mouse model. J. Vis. Exp. 27, 51303 (2014).</Citation></Reference><Reference><Citation>Sugiyama, K. &amp; Tanaka, K. Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice. Biochem. Biophys. Res. Commun. 497, 689&#x2013;693 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.02.132</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessen, H. G. et al. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp. Neurol. 201, 293&#x2013;300 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.04.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang, D. W. et al. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 20, 1745&#x2013;1751 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03648.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao, E. Y. et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451&#x2013;1463 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdin, E. NAD<sup>+</sup> in aging, metabolism, and neurodegeneration. Science 350, 1208&#x2013;1213 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac4854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney, N. J., Laux, D. C. &amp; Cohen, P. S. Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3504&#x2013;3511 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8751891</ArticleId><ArticleId IdType="pmc">174255</ArticleId></ArticleIdList></Reference><Reference><Citation>Golko-Perez, S., Amit, T., Bar-Am, O., Youdim, M. B. H. &amp; Weinreb, O. A novel iron chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1<sup>G93A</sup> ALS mice. Neurotox. Res. 31, 230&#x2013;244 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-016-9677-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpulla, R. C., Vega, R. B. &amp; Kelly, D. P. Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol. Metab. 23, 459&#x2013;466 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2012.06.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron, R. et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 281, E1340&#x2013;E1346 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.2001.281.6.E1340</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, M. J. &amp; Scarpulla, R. C. NRF-1: a trans-activator of nuclear-encoded respiratory genes in animal cells. Genes Dev. 4, 1023&#x2013;1034 (1990).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.4.6.1023</ArticleId></ArticleIdList></Reference><Reference><Citation>Virbasius, C. A., Virbasius, J. V. &amp; Scarpulla, R. C. NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. Genes Dev. 7, 2431&#x2013;2445 (1993).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.7.12a.2431</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson, S. J. et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4, 222&#x2013;231 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.24373</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy, M. et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163, 1428&#x2013;1443 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.10.048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros, T. et al. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J. Vis. Exp. 104, 1&#x2013;6 (2015).</Citation></Reference><Reference><Citation>Hansson, G. C. &amp; Johansson, M. E. V. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Gut Microbes 1, 51&#x2013;54 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.1.1.10470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x15b;niewski, J. R., Zougman, A., Nagaraj, N. &amp; Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359&#x2013;362 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1322</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder, B. O. et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe 23, 27&#x2013;40.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber, J., Mann, M. &amp; Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896&#x2013;1906 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, J. &amp; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367&#x2013;1372 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966&#x2013;968 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq054</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 0008 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb4100050</ArticleId></ArticleIdList></Reference><Reference><Citation>Adiconis, X. et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat. Methods 10, 623&#x2013;629 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2483</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335&#x2013;336 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.f.303</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581&#x2013;583 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3869</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss, S. et al. Normalization and microbial differential abundance strategies depend upon data characteristics. Microbiome 5, 27 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0237-y</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610&#x2013;618 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2011.139</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco-Sola, S., Sammeth, M., Guig&#xf3;, R. &amp; Ribeca, P. The GEM mapper: fast, accurate and versatile alignment by filtration. Nat. Methods 9, 1185&#x2013;1188 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2221</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443&#x2013;1448 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, D354&#x2013;D357 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj102</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchfink, B., Xie, C. &amp; Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59&#x2013;60 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3176</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead, B. &amp; Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357&#x2013;359 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimand, J., Kull, M., Peterson, H., Hansen, J. &amp; Vilo, J. g:Profiler&#x2014;a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193&#x2013;W200 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>